Speeches
LC: Speech by SFH on proposed resolution under Pharmacy and Poisons Ordinance
Following is the speech by the Secretary for Food and Health, Dr Ko
Wing-man, in moving a motion on the proposed resolution on the Pharmacy and
Poisons (Amendment)(No. 5) Regulation 2013 and the Poisons List
(Amendment)(No. 5) Regulation 2013 under the Pharmacy and Poisons Ordinance
in the Legislative Council today (October 16):
Mr President,
I move that the motion under my name, as printed on the Agenda, be passed.
Currently, we regulate the sale and supply of pharmaceutical products
through a registration and monitoring system set up in accordance with the
Pharmacy and Poisons Ordinance. The Ordinance maintains several Schedules
under the Pharmacy and Poisons Regulations and a Poisons List under the
Poisons List Regulations. Pharmaceutical products put under different parts
of the Poisons List and different Schedules are subject to different levels
of control in regard to the conditions of sale and keeping of records.
For the protection of public health, some pharmaceutical products can only
be sold in pharmacies under the supervision of registered pharmacists and in
their presence. For certain pharmaceutical products, proper records of the
particulars of the sale must be kept, including the date of sale, the name
and address of the purchaser, the name and quantity of the medicine and the
purpose for which it is required. The sale of some pharmaceutical products
must be authorised by prescription from a registered medical practitioner,
dentist or veterinary surgeon.
Arising from an application for registration of one pharmaceutical product,
the Pharmacy and Poisons Board proposes to add the following substance to
Part I of the Poisons List and the First and Third Schedules to the Pharmacy
and Poisons Regulations:
(a) Glycopyrronium; its salts.
Pharmaceutical products containing the above substance must then be sold in
pharmacies under the supervision of registered pharmacists and in their
presence, with the support of prescriptions.
For amendment regulations concerning the adding of the above substance to
Part I of the Poisons List and the First and Third Schedules to the Pharmacy
and Poisons Regulations, we propose them to take immediate effect upon
gazettal on October 18, 2013, to allow early control and sale of the
relevant medicine.
The two Amendment Regulations are made by the Pharmacy and Poisons Board,
which is a statutory authority established under the Ordinance to regulate
pharmaceutical products. The Board comprises members engaged in the
pharmacy, medical and academic professions. The Board considers the proposed
amendments necessary in view of the potency, toxicity and potential side
effects of the medicine concerned.
With these remarks, Mr President, I hope members could support the motion.
Thank you.
Ends/Wednesday, October 16, 2013
Issued at HKT 15:10
NNNN